Intuitive Surgical is trading 4.2% down at $372.50 in after-hours trading, despite reporting Q2 2026 financial results that beat analyst estimates for both revenue and EPS.
- The company reported Q2 2026 revenue of $2.89 billion, up 19% year-over-year, exceeding the consensus estimate of $2.82 billion.
- Non-GAAP EPS came in at $2.80, surpassing the analyst estimate of $2.51 by $0.29.
- The stock's year-to-date decline has been driven by valuation compression and tariff concerns amid a broader risk-off move in high-multiple tech and healthcare names.